SuperworthKiora Pharmaceuticals market cap KPRX
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $10.1M
- Highest close in our data
- $132.8M
- Jul 2015
Kiora Pharmaceuticals is worth $10.1M at the close on Oct 23, 2026, at $2.29 a share.
That is up 15% over the last year and down 58% over five years.
Its highest close in our data was $132.8M in Jul 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $10.1M | $7.3M | $12.2M | +40% |
| 2025 | $7.2M | $6.9M | $12.1M | −27% |
| 2024 | $9.9M | $4.1M | $18.5M | +146% |
| 2023 | $4M | $1.2M | $8.5M | +3% |
| 2022 | $3.9M | $1.9M | $12.7M | −80% |
| 2021 | $19.1M | $11M | $36.6M | −16% |
| 2020 | $22.8M | $15.3M | $35M | −33% |
| 2019 | $33.9M | $7.4M | $33.9M | +63% |
| 2018 | $20.7M | $6.1M | $26M | +13% |
| 2017 | $18.4M | $12.4M | $29.9M | +18% |
| 2016 | $15.6M | $12.5M | $31.2M | −26% |
| 2015 | $21M | $19.6M | $132.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Kiora Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| KPRXKiora Pharmaceuticals | $10.1M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Kiora Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.